Template:CHA2DS2VASc Calculator: Difference between revisions
(Remove includeonly tags so calculator renders on template page too) |
(Add wikilinks: anticoagulation) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 5: | Line 5: | ||
[[Category:Calculator templates]] | [[Category:Calculator templates]] | ||
</noinclude><div class="calculator-container" data-calculator-refresh-on-load="true"> | </noinclude>=== CHA₂DS₂-VASc Score === | ||
<div class="calculator-container" data-calculator-refresh-on-load="true"> | |||
{| class="wikitable" style="width:100%; border-collapse:collapse;" | {| class="wikitable" style="width:100%; border-collapse:collapse;" | ||
|+ style="font-size:16px; font-weight:bold; padding:8px; background:#4a90d9; color:white;" | CHA₂DS₂-VASc Score Calculator | |+ style="font-size:16px; font-weight:bold; padding:8px; background:#4a90d9; color:white;" | CHA₂DS₂-VASc Score Calculator | ||
| Line 57: | Line 58: | ||
|- | |- | ||
| style="background:#f39c12; color:white; text-align:center; font-weight:bold;" | 1 | | style="background:#f39c12; color:white; text-align:center; font-weight:bold;" | 1 | ||
| '''Low-Moderate Risk''' — 0.6% annual stroke risk (males). Consider anticoagulation (esp. if not due to female sex alone). | | '''Low-Moderate Risk''' — 0.6% annual stroke risk (males). Consider [[Anticoagulation|anticoagulation]] (esp. if not due to female sex alone). | ||
|- | |- | ||
| style="background:#e74c3c; color:white; text-align:center; font-weight:bold;" | ≥2 | | style="background:#e74c3c; color:white; text-align:center; font-weight:bold;" | ≥2 | ||
| '''Moderate-High Risk''' — ≥2.2% annual stroke risk. Oral anticoagulation recommended. | | '''Moderate-High Risk''' — ≥2.2% annual stroke risk. Oral anticoagulation recommended. | ||
|} | |||
{| class="wikitable" style="width:100%; margin-top:4px; font-size:90%;" | |||
! References | |||
|- | |||
| | |||
* Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. ''Chest.'' 2010;137(2):263-272. PMID 19762550. | |||
* January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 Guideline for Management of Patients With Atrial Fibrillation. ''J Am Coll Cardiol.'' 2019;74(1):104-132. PMID 30703431. | |||
|} | |} | ||
</div> | </div> | ||
Latest revision as of 16:49, 21 March 2026
Interactive CHA₂DS₂-VASc Score calculator for atrial fibrillation stroke risk. Requires the calculator gadget.
Usage: {{CHA2DS2VASc Calculator}}
CHA₂DS₂-VASc Score
| Criteria | No (0) | Yes |
|---|---|---|
| Congestive heart failure (or LVEF ≤40%) | 1 | (+1) |
| Hypertension | 1 | (+1) |
| Age ≥75 years | 1 | (+2) |
| Diabetes mellitus | 1 | (+1) |
| Stroke/TIA/thromboembolism | 1 | (+2) |
| Vascular disease (prior MI, PAD, aortic plaque) | 1 | (+1) |
| Age 65–74 years | 1 | (+1) |
| Sex category (female) | 1 | (+1) |
| CHA₂DS₂-VASc Score | / 9 | |
| Interpretation | |
|---|---|
| 0 | Low Risk — 0.2% annual stroke risk (males). Anticoagulation generally not recommended. |
| 1 | Low-Moderate Risk — 0.6% annual stroke risk (males). Consider anticoagulation (esp. if not due to female sex alone). |
| ≥2 | Moderate-High Risk — ≥2.2% annual stroke risk. Oral anticoagulation recommended. |
| References |
|---|
|